Cite

HARVARD Citation

    Verry, C. et al. (2021). Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial). Radiotherapy and oncology. pp. 159-165. [Online]. 
  
Back to record